The field of immuno-oncology has shown continuous and accelerated growth since 2000 with clear signs of further expansion. The success of immunotherapeutic drugs in treatment of hard-to-treat cancers has given patients a new lease on life and speaks to the enormous potential of immuno-oncology. Accelerating interest means the volume of information (in terms of scientific publications) that is becoming available can be overwhelming. Gaining insights from large volumes of data is invaluable in guiding future growth of the field. Achieving this lofty goal though is extremely challenging.